REDEMPLO

PLOZASIRAN · Arrowhead Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REDEMPLO, covering 2025-11-18 to 2026-07-03. Get the full timeline:

Most recent: EMA Authorised: Redemplo (plozasiran sodium) — Arrowhead Pharmaceuticals Ireland Limited